Status:
COMPLETED
Impact of a Mobile Application (Pacifica) on Stress, Anxiety, and Depression
Lead Sponsor:
Pacifica Labs Inc.
Conditions:
Anxiety
Stress
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is designed to examine the efficacy of a mobile application implementation of existing best practices in mental health treatment for managing stress, anxiety, and depression.
Detailed Description
Over 61 million adults in the U.S. experience mental illness in a given year, and only 1 in 3 will receive professional care due to difficulties with access to care, stigma, cost, or time involved in ...
Eligibility Criteria
Inclusion
- Target disease: participants who score between 5 and 14 on the GAD-7 OR between 5 and 14 on the PHQ-8 and are therefore believed to be experience mild to moderate depression or anxiety
- No previous experience using the Pacifica app.
- Regular access to a smartphone
- Fluent in English
- Living in U.S.
Exclusion
- Below 5 or over 14 on GAD-7 or below 5 or over 14 on PHQ-8
- Positive response on screener of presence of diagnosis of bipolar disorder, schizophrenia, other psychotic spectrum disorder, organic brain disease, currently pregnant
Key Trial Info
Start Date :
November 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2018
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03333707
Start Date
November 2 2017
End Date
May 10 2018
Last Update
May 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pacifica Labs, Inc.
San Francisco, California, United States, 94110